The New Reality of Peptide Analysis
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
False
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
December 12, 2024
2 min read
How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research
October 1, 2024
10 min read
Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons
October 1, 2024
1 min read
Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents
October 2, 2024
2 min read
Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment
Affiliations:
Specialties:
Areas of Expertise:
False
4 Topic Commentaries
The New Reality of Peptide Analysis
The New Reality of Peptide Analysis
Joshua J. Coon, PhD
Mass spectrometry and proteomics
•University of Wisconsin–Madison
Mia Huang, PhD
Chemical glycobiology; mass spectrometry
•Scripps Research
Alan W. Partin, MD, PhD
Urology; quantitative glycoproteomics
•Johns Hopkins University School of Medicine
Kevin T. Uno, PhD
Paleoproteomics; LC–MS/MS peptide analysis
•Harvard University
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.